The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment and management of cardiovascular risk factors among U.S. Veterans with newly diagnosed prostate cancer.
 
Lova Sun
No Relationships to Disclose
 
Ravi Bharat Parikh
Stock and Other Ownership Interests - GNS Healthcare; Google; Merck
Consulting or Advisory Role - Cancer Study Group; GNS Healthcare
Travel, Accommodations, Expenses - Conquer Cancer Foundation; Flatiron Health
 
Kyle William Robinson
Consulting or Advisory Role - Bayer
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)
 
David J. Vaughn
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Astellas Pharma; Merck Sharp & Dohme; Roche/Genentech
 
Vivek Narayan
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Merck; Modra Pharmaceuticals; Pfizer/EMD Serono
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck; Pfizer (Inst)
Travel, Accommodations, Expenses - Merck
 
Bonnie Ky
Honoraria - UpToDate
Consulting or Advisory Role - American College of Cardiology; Bioinvent; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Mateon Therapeutics; Roche; Roche
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Pfizer; Roche; Singulex
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure; Pending patent application on the use of IgE as a biomarker of cardiotoxicity